在MESA中,心率碎片化与功能下降之间的关联:证据与表交性降解相一致
Madalena D Costa1, Susan Redline2, Nisha Bansal3
1Division of Interdisciplinary Medicine and Biotechnology, Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States.
概括
通过心率碎片化 (HRF) 测量,降低了副交感活动,与慢性病 (CKD) 风险增加和功能衰退的加快有关. 这一发现凸显了HRF作为脏健康的潜在生物标志物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 自主神经科学 自主神经科学
背景情况:
- 交感性过度活跃是已知的慢性病 (CKD) 病原体的贡献者.
- 副交感系统在维持功能中的作用不太清楚.
- 动物模型表明,副交感活动通过抗炎和心血管路径影响功能.
研究的目的:
- 为了研究心率碎片化 (HRF),一个新型的非侵入性标记器的副交感功能,和流行的CKD之间的关联.
- 为了检查HRF与估计的膜过率 (eGFR) 在大约5年的纵向变化之间的关系.
主要方法:
- 分析了多民族动脉样硬化研究 (MESA) 的1388名参与者,并进行了多睡眠电图记录.
- HRF被评估为一种表征性活动的度量.
- 统计模型被用于评估与CKD概率和eGFR下降的关联,并对并发症进行调整.
主要成果:
- 较高的HRF,表明降低了副交感功能,与患有常见CKD的可能性增加有关 (RR: 1.15).
- 较高的HRF也与eGFR随时间的推移而大幅下降有关 (0.86 mL/min/1.73 m2/SD增加).
- 这些关联在调整年龄,高血压,糖尿病和基线CKD状态后仍然显著.
结论:
- 降低的副交感活性,如高HRF所示,与普遍的CKD和加速的功能下降有关.
- HRF可以作为病风险分层和监测的非侵入性生物标志物.
- 这些发现支持了副交感功能在稳定中的作用,并表明了针对自主性向干预的潜力.
相关概念视频
01:29Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
01:17Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
01:31Regulation of Heart Rates
2.2K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
2.2K
01:22Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
01:24Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107